Uranium Royalty Corp. shares rise 1.95% after-hours following XOMA Royalty Corporation's acquisition of Mural Oncology.

Uranium Royalty Corp. rose 1.95% in after-hours trading. The company announced that XOMA Royalty Corporation (NasdaqGM:XOMA) entered into a definitive agreement to acquire Mural Oncology plc (NasdaqGM:MURA) for $35.3 million on August 20, 2025. A cash consideration valued at $2.035 per share will be paid by XOMA Royalty Corporation for 17.324771 million shares. XOMA Royalty Corporation will pay an earnout/contingent payment of $3.56 million cash.